pharma · Severe, Refractory Systemic Lupus Erythematosus · Refractory Progressive Multiple Sclerosis · AUTL
Autolus
Autolus GmbH
Autolus trial registry — 17 ClinicalTrials.gov studies with program phase, status, and indication context.
Munich, Bayern 81377, DE HQ
117 Employees
Public company Type
AUTL · NYSE Ticker
Company details
- Status
- Public
- HQ
- Munich, Bayern 81377, DE
- Employees
- 117
- Programs
- 16
- Drugs
- 17
- Patents
- 49
Autolus clinical trials
Registry index of 17 ClinicalTrials.gov studies linked to Autolus programs — each row shows trial ID, program name, phase, status, and indication.
Autolus trial registry — 17 ClinicalTrials.gov studies with program phase, status, and indication context.
Recent trial activity
Latest clinical program signals indexed for Autolus.
-
Genoxal polvo para solución inyectable y para... — Phase 2
Clinical update -
AUTO1-SL1 — Phase 1
Clinical update -
AUTO1-SL2 — Phase 2
Clinical update -
AUTO1-MS1 — Phase 1
Clinical update -
AUTO-LT1 — Phase 2
Clinical update -
Obecabtagene autoleucel (obe-cel) — Phase 1
Clinical update -
AUTO CAR T cell therapy — Phase 2
Clinical update -
Obecabtagene autoleucel (obe-cel) — Phase 1
Clinical update
Trial registry
-
CTIS ↗ - 2024-511684-28-00CTIS ↗
AUTO-LT1
Potential malignancy in patients who received treatment with Autolus CAR T cell therapy.
- 2024-512903-38-00CTIS ↗
Genoxal polvo para solución inyectable y para...
Relapsed or refractory B cell acute lymphoblastic leukaemia
-
CTIS ↗ -
CTIS ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ - NCT03628612CT.gov ↗
AUTO CAR T cell therapy
Patients Followed for up to 15 Years Following Their First Dose of AUTO CAR T Cell Therapy
-
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗